{"id":"W3120915669","doi":"10.1093/ofid/ofaa439.426","title":"116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results from the POLAR Study","year":2020,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Rilpivirine; Medicine; Adverse effect; Tolerability; Human immunodeficiency virus (HIV); Internal medicine; Viral load; Antiretroviral therapy; Virology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001197476,0.0004055624,0.0006991909,0.0001857617,0.0001874035,0.0006055973,0.0002583823,0.0004101909,0.003663252],"category_scores_gemma":[0.0009143623,0.000247259,0.0005312694,0.0002345286,0.0003839563,0.0003812763,0.0002164726,0.0007547199,0.0009247353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002758421,"about_ca_system_score_gemma":0.0003600211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009296386,"about_ca_topic_score_gemma":0.001460668,"domain_scores_codex":[0.9995493,0.0002484656,0.0000410651,0.0000520863,0.00006011017,0.00004894347],"domain_scores_gemma":[0.9992711,0.0002185341,0.000171402,0.00004918468,0.00009404252,0.0001957672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7422609,0.00980866,0.08651426,0.0008552817,0.001352049,0.0002463938,0.000183884,0.0006710766,0.05317659,0.00008342493,0.002844741,0.1020028],"study_design_scores_gemma":[0.1801941,0.5537984,0.2375886,0.0001448266,0.002063206,0.0008547879,0.0003367984,0.001753456,0.01568154,0.0001306826,0.007392813,0.00006080863],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948918,0.001957833,0.000218514,0.00007215583,0.0000416974,0.0002149009,0.001114382,0.00002621394,0.001462475],"genre_scores_gemma":[0.9960097,0.0005279647,0.0003081931,0.0001096106,0.00005332007,0.00009672989,0.001848501,0.00000834269,0.001037621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003663252,"threshold_uncertainty_score":0.01225477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01793653676494958,"score_gpt":0.2866787662986212,"score_spread":0.2687422295336717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}